Filing Details
- Accession Number:
- 0000899243-17-004558
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-17 17:01:00
- Reporting Period:
- 2017-02-16
- Filing Date:
- 2017-02-17
- Accepted Time:
- 2017-02-17 17:01:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695496 | Thomas Brida | C/O Invitae Corporation 458 Brannan Street San Francisco CA 94107 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-02-16 | 766 | $9.69 | 24,720 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale was made in connection with covering tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- Represents a weighted average sale price for multiple transactions at prices ranging from $9.6872 to $9.51, inclusive. Upon request by the Commission staff, the Company or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 16, 2017 at each separate price.